Skip to main content

Advertisement

Erratum to: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics

The original article was published in BMC Research Notes 2014 7:360

Correction

After publication of this work [1], it has come to our attention that there is an error in the author list of the initial version of this manuscript; rather than Ernest J Lam, the second author of the manuscript should be listed as Ernest T Lam.

We publish this correction to update the author list with this information. The correct author list is as follows:

Gunjan D Hariani, Ernest T Lam, Tammy Havener, Pui-Yan Kwok, Howard L McLeod, Michael J Wagner and Alison A Motsinger-Reif

This error was introduced during the final production process and the editors of BMC Research Notes apologise for any inconvenience caused.

References

  1. 1.

    Hariani GD, Lam EJ, Havener T, Kwok PY, McLeod HL, Wagner MJ, Motsinger-Reif AA: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics. BMC Res Notes. 2014, 7: 360-10.1186/1756-0500-7-360.

Download references

Author information

Correspondence to Alison A Motsinger-Reif.

Additional information

The online version of the original article can be found at 10.1186/1756-0500-7-360

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark